These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2019279)

  • 1. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
    Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
    Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography.
    Goulding P; Burjan A; Smith R; Lawson R; Snowden J; Northen B; Neary D; Testa H
    Eur J Nucl Med; 1990; 17(1-2):77-82. PubMed ID: 2083546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.
    Wang SJ; Liu RS; Liu HC; Lin KN; Shan DE; Liao KK; Fuh JL; Lee LS
    Eur J Nucl Med; 1993 Apr; 20(4):339-44. PubMed ID: 8491227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
    Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M
    Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
    Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
    Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
    Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.
    Spampinato U; Habert MO; Mas JL; Bourdel MC; Ziegler M; de Recondo J; Askienazy S; Rondot P
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):787-92. PubMed ID: 1955897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.
    Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Ichimiya A; Masuda K
    Ann Nucl Med; 1990 Nov; 4(3):75-82. PubMed ID: 2083138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes.
    Keymeulen B; de Metz K; Cluydts R; Bossuyt A; Somers G
    Eur J Nucl Med; 1996 Feb; 23(2):163-8. PubMed ID: 8925851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.